ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Wisconsin » Internal Medicine

Top Internal Medicine Prescribers in Wisconsin

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
KARIM BAKHTIAR MD

Internal Medicine

36,672

$2.03M

682
471 are 65+

14%
patients receiving schedule two controlled substances

Avg: 6%

22%
patients receiving schedule three controlled substances

Avg: 9%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 23%

$55
Average prescription price

Avg: $55

ANILKUMAR DONIPARTHI MD

Internal Medicine

28,198

$1.8M

558
466 are 65+

14%
patients receiving schedule two controlled substances

Avg: 6%

16%
patients receiving schedule three controlled substances

Avg: 9%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

30%
prescriptions for brand name drugs

Avg: 23%

$64
Average prescription price

Avg: $55

MIR QURYSHI MD

Internal Medicine

27,524

$1.36M

736
659 are 65+

9%
patients receiving schedule two controlled substances

Avg: 6%

9%
patients receiving schedule three controlled substances

Avg: 9%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 23%

$50
Average prescription price

Avg: $55

STEVE CHANG MD

Internal Medicine

26,126

$1.35M

579
527 are 65+

13%
patients receiving schedule two controlled substances

Avg: 6%

15%
patients receiving schedule three controlled substances

Avg: 9%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 23%

$52
Average prescription price

Avg: $55

DANIEL LOPEZ-TAN MD

Internal Medicine

24,443

$1.52M

454
401 are 65+

19%
patients receiving schedule two controlled substances

Avg: 6%

27%
patients receiving schedule three controlled substances

Avg: 9%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

28%
prescriptions for brand name drugs

Avg: 23%

$62
Average prescription price

Avg: $55

CLIFFORD POPLAR M.D.

Internal Medicine

23,269

$1.09M

676
602 are 65+

6%
patients receiving schedule two controlled substances

Avg: 6%

14%
patients receiving schedule three controlled substances

Avg: 9%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

21%
prescriptions for brand name drugs

Avg: 23%

$47
Average prescription price

Avg: $55

MUHAMMAD MIAN MD

Internal Medicine

22,220

$1.05M

717
649 are 65+

9%
patients receiving schedule two controlled substances

Avg: 6%

13%
patients receiving schedule three controlled substances

Avg: 9%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 23%

$47
Average prescription price

Avg: $55

PRADEEP GIRIYAPPA M.D.

Internal Medicine

21,449

$1.04M

650
537 are 65+

4%
patients receiving schedule two controlled substances

Avg: 6%

12%
patients receiving schedule three controlled substances

Avg: 9%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 23%

$49
Average prescription price

Avg: $55

BRUCE FENSTER MD

Internal Medicine

21,415

$1.15M

769
621 are 65+

8%
patients receiving schedule two controlled substances

Avg: 6%

14%
patients receiving schedule three controlled substances

Avg: 9%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

21%
prescriptions for brand name drugs

Avg: 23%

$54
Average prescription price

Avg: $55

KRISHNA PANDEY M.D.

Internal Medicine

21,323

$1.25M

697
441 are 65+

22%
patients receiving schedule two controlled substances

Avg: 6%

8%
patients receiving schedule three controlled substances

Avg: 9%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

27%
prescriptions for brand name drugs

Avg: 23%

$59
Average prescription price

Avg: $55

CURTIS HANCOCK MD

Internal Medicine

21,231

$1M

768
640 are 65+

9%
patients receiving schedule two controlled substances

Avg: 6%

12%
patients receiving schedule three controlled substances

Avg: 9%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 23%

$47
Average prescription price

Avg: $55

MATTHEW KRAEMER DO

Internal Medicine

20,357

$874K

879
780 are 65+

8%
patients receiving schedule two controlled substances

Avg: 6%

11%
patients receiving schedule three controlled substances

Avg: 9%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

20%
prescriptions for brand name drugs

Avg: 23%

$43
Average prescription price

Avg: $55

JACK ANDERSON MD

Internal Medicine

19,960

$993K

1028
918 are 65+

6%
patients receiving schedule two controlled substances

Avg: 6%

10%
patients receiving schedule three controlled substances

Avg: 9%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

21%
prescriptions for brand name drugs

Avg: 23%

$50
Average prescription price

Avg: $55

MICHAEL POST MD

Internal Medicine

18,923

$939K

610
513 are 65+

8%
patients receiving schedule two controlled substances

Avg: 6%

10%
patients receiving schedule three controlled substances

Avg: 9%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

21%
prescriptions for brand name drugs

Avg: 23%

$50
Average prescription price

Avg: $55

GEORGIA BRUNETTE

Internal Medicine

18,580

$852K

711
581 are 65+

6%
patients receiving schedule two controlled substances

Avg: 6%

14%
patients receiving schedule three controlled substances

Avg: 9%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 23%

$46
Average prescription price

Avg: $55

GIAN DAROACH MD

Internal Medicine

18,066

$820K

561
455 are 65+

5%
patients receiving schedule two controlled substances

Avg: 6%

12%
patients receiving schedule three controlled substances

Avg: 9%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

21%
prescriptions for brand name drugs

Avg: 23%

$45
Average prescription price

Avg: $55

GABRIEL MIHAILESCU MD

Internal Medicine

17,939

$1.04M

723
536 are 65+

9%
patients receiving schedule two controlled substances

Avg: 6%

11%
patients receiving schedule three controlled substances

Avg: 9%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 23%

$58
Average prescription price

Avg: $55

JOHN STEINER MD

Internal Medicine

17,827

$744K

679
602 are 65+

6%
patients receiving schedule two controlled substances

Avg: 6%

9%
patients receiving schedule three controlled substances

Avg: 9%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

16%
prescriptions for brand name drugs

Avg: 23%

$42
Average prescription price

Avg: $55

KEVIN SANDMIRE MD

Internal Medicine

17,750

$842K

822
710 are 65+

3%
patients receiving schedule two controlled substances

Avg: 6%

7%
patients receiving schedule three controlled substances

Avg: 9%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

20%
prescriptions for brand name drugs

Avg: 23%

$47
Average prescription price

Avg: $55

ROBERT TURNER M.D.

Internal Medicine

16,806

$891K

549
430 are 65+

12%
patients receiving schedule two controlled substances

Avg: 6%

10%
patients receiving schedule three controlled substances

Avg: 9%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

21%
prescriptions for brand name drugs

Avg: 23%

$53
Average prescription price

Avg: $55

LYNNE LANGLOIS D.O.

Internal Medicine

16,759

$1M

476
410 are 65+

15%
patients receiving schedule two controlled substances

Avg: 6%

19%
patients receiving schedule three controlled substances

Avg: 9%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

27%
prescriptions for brand name drugs

Avg: 23%

$60
Average prescription price

Avg: $55

THOMAS TACKMAN MD

Internal Medicine

16,423

$807K

560
355 are 65+

8%
patients receiving schedule two controlled substances

Avg: 6%

8%
patients receiving schedule three controlled substances

Avg: 9%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

19%
prescriptions for brand name drugs

Avg: 23%

$49
Average prescription price

Avg: $55

RAYMOND BACHHUBER MD

Internal Medicine

16,133

$1.94M

543
384 are 65+

11%
patients receiving schedule two controlled substances

Avg: 6%

14%
patients receiving schedule three controlled substances

Avg: 9%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 23%

$120
Average prescription price

Avg: $55

DAVID MOMONT MD

Internal Medicine

16,117

$813K

607
558 are 65+

13%
patients receiving schedule two controlled substances

Avg: 6%

17%
patients receiving schedule three controlled substances

Avg: 9%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

21%
prescriptions for brand name drugs

Avg: 23%

$50
Average prescription price

Avg: $55

RICHARD THEOBALD MD

Internal Medicine

15,949

$733K

507
381 are 65+

7%
patients receiving schedule two controlled substances

Avg: 6%

14%
patients receiving schedule three controlled substances

Avg: 9%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 23%

$46
Average prescription price

Avg: $55

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank